These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 22952809)
1. PR3 and elastase alter PAR1 signaling and trigger vWF release via a calcium-independent mechanism from glomerular endothelial cells. Tull SP; Bevins A; Kuravi SJ; Satchell SC; Al-Ani B; Young SP; Harper L; Williams JM; Rainger GE; Savage CO PLoS One; 2012; 7(8):e43916. PubMed ID: 22952809 [TBL] [Abstract][Full Text] [Related]
2. Neutrophil Protease Cleavage of Von Willebrand Factor in Glomeruli - An Anti-thrombotic Mechanism in the Kidney. Tati R; Kristoffersson AC; Manea Hedström M; Mörgelin M; Wieslander J; van Kooten C; Karpman D EBioMedicine; 2017 Feb; 16():302-311. PubMed ID: 28139439 [TBL] [Abstract][Full Text] [Related]
3. Differential actions of PAR2 and PAR1 in stimulating human endothelial cell exocytosis and permeability: the role of Rho-GTPases. Klarenbach SW; Chipiuk A; Nelson RC; Hollenberg MD; Murray AG Circ Res; 2003 Feb; 92(3):272-8. PubMed ID: 12595338 [TBL] [Abstract][Full Text] [Related]
4. Neutrophil elastase and proteinase-3 trigger G protein-biased signaling through proteinase-activated receptor-1 (PAR1). Mihara K; Ramachandran R; Renaux B; Saifeddine M; Hollenberg MD J Biol Chem; 2013 Nov; 288(46):32979-90. PubMed ID: 24052258 [TBL] [Abstract][Full Text] [Related]
5. Differential regulation of endothelial exocytosis of P-selectin and von Willebrand factor by protease-activated receptors and cAMP. Cleator JH; Zhu WQ; Vaughan DE; Hamm HE Blood; 2006 Apr; 107(7):2736-44. PubMed ID: 16332977 [TBL] [Abstract][Full Text] [Related]
6. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry. Loew D; Perrault C; Morales M; Moog S; Ravanat C; Schuhler S; Arcone R; Pietropaolo C; Cazenave JP; van Dorsselaer A; Lanza F Biochemistry; 2000 Sep; 39(35):10812-22. PubMed ID: 10978167 [TBL] [Abstract][Full Text] [Related]
7. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases. Steppich BA; Seitz I; Busch G; Stein A; Ott I Thromb Haemost; 2008 Dec; 100(6):1068-75. PubMed ID: 19132232 [TBL] [Abstract][Full Text] [Related]
8. Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4. Ramachandran R; Sadofsky LR; Xiao Y; Botham A; Cowen M; Morice AH; Compton SJ Am J Physiol Lung Cell Mol Physiol; 2007 Mar; 292(3):L788-98. PubMed ID: 17142351 [TBL] [Abstract][Full Text] [Related]
9. Mitochondrial reactive oxygen species: a common pathway for PAR1- and PAR2-mediated tissue factor induction in human endothelial cells. Banfi C; Brioschi M; Barbieri SS; Eligini S; Barcella S; Tremoli E; Colli S; Mussoni L J Thromb Haemost; 2009 Jan; 7(1):206-16. PubMed ID: 18983479 [TBL] [Abstract][Full Text] [Related]
10. Distribution of the granulocyte serine proteinases proteinase 3 and elastase in human glomerulonephritis. Mrowka C; Csernok E; Gross WL; Feucht HE; Bechtel U; Thoenes GH Am J Kidney Dis; 1995 Feb; 25(2):253-61. PubMed ID: 7847352 [TBL] [Abstract][Full Text] [Related]
11. Distinct roles of protease-activated receptors in signal transduction regulation of endothelial nitric oxide synthase. Suzuki H; Motley ED; Eguchi K; Hinoki A; Shirai H; Watts V; Stemmle LN; Fields TA; Eguchi S Hypertension; 2009 Feb; 53(2):182-8. PubMed ID: 19064814 [TBL] [Abstract][Full Text] [Related]
12. Statins prevent tissue factor induction by protease-activated receptors 1 and 2 in human umbilical vein endothelial cells in vitro. Banfi C; Brioschi M; Lento S; Pirillo A; Galli S; Cosentino S; Tremoli E; Mussoni L J Thromb Haemost; 2011 Aug; 9(8):1608-19. PubMed ID: 21605334 [TBL] [Abstract][Full Text] [Related]
13. Protease-activated receptor-1 (PAR1) and PAR2 but not PAR4 mediate relaxations in lower esophageal sphincter. Huang SC Regul Pept; 2007 Jul; 142(1-2):37-43. PubMed ID: 17335921 [TBL] [Abstract][Full Text] [Related]
14. Tissue factor induction by protease-activated receptor 1 requires intact caveolin-enriched membrane microdomains in human endothelial cells. Banfi C; Brioschi M; Barcella S; Pignieri A; Parolari A; Biglioli P; Tremoli E; Mussoni L J Thromb Haemost; 2007 Dec; 5(12):2437-44. PubMed ID: 17848177 [TBL] [Abstract][Full Text] [Related]
15. A novel protein C-factor VII chimera provides new insights into the structural requirements for cytoprotective protease-activated receptor 1 signaling. Gleeson EM; McDonnell CJ; Soule EE; Willis Fox O; Rushe H; Rehill A; Smith OP; O'Donnell JS; Preston RJS J Thromb Haemost; 2017 Nov; 15(11):2198-2207. PubMed ID: 28834159 [TBL] [Abstract][Full Text] [Related]
16. Protease-activated receptors-1 and -2 can mediate endothelial barrier protection: role in factor Xa signaling. Feistritzer C; Lenta R; Riewald M J Thromb Haemost; 2005 Dec; 3(12):2798-805. PubMed ID: 16359518 [TBL] [Abstract][Full Text] [Related]
17. Dual blockade of protease-activated receptor 1 and 2 additively ameliorates diabetic kidney disease. Mitsui S; Oe Y; Sekimoto A; Sato E; Hashizume Y; Yamakage S; Kumakura S; Sato H; Ito S; Takahashi N Am J Physiol Renal Physiol; 2020 May; 318(5):F1067-F1073. PubMed ID: 32200667 [TBL] [Abstract][Full Text] [Related]